The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Sensory neuropeptides: their role in inflammation and wound healing
Abstract
Vasoactive neuropeptides including substance P and calcitonin gene-related peptide (CGRP) are localised in sensory nerves which innervate blood vessels. These are the major vasoactive neuropeptides released from sensory nerve endings and both have been suggested to have roles in inflammatory and cardiovascular disease. The neuropeptides have potent effects on microvascular tone and permeability, which are seen soon after release from perivascular nerves. There is also evidence that neuropeptides can affect various activities of inflammatory cells and that sensory nerves play a role in the recovery of the healthy microcirculation during wound healing phases. This review concentrates on evidence that the neuropeptides substance P, acting via tachykinin NK1 and NK2 receptors, and CGRP, acting via CGRP1 receptors, play a pro-inflammatory role in disease and a beneficial role in wound healing. In addition, results from clinical trials of recently developed neuropeptide antagonists are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, genetic deletion or blockade of CGRP receptors has been suggested to be detrimental to wound healing58–60.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [58]
Citations
Cites
Items 201–205 of 205
Herzberg, U., Murtaugh, M. P., Mullett, M. A., & Beitz, A. J. (1995) · Neuroreport · doi:10.1097/00001756-199509000-00016 · Cited by 9
GEPPETTI, P., & Holzer, P. (1996) · Florence Research (University of Florence) · Cited by 7
Dermal nerves in human diabetic subjects
Johnson, P. C., & Doll, S. C. (1984) · Diabetes · doi:10.2337/diabetes.33.3.244 · Cited by 5
Berkowitz-Balshayi, C., & Becker, Y. (1996) · PubMed · Cited by 4
Heerwagen, C., Pabst, R., & Westermann, J. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03683.x · Cited by 3
Research works printed but not linked: 5
- Bennett, 1996, Nerve growth factor induces an immediate and also a late phase of oedema formation in rat skin, Br. J. Pharmacol., 119, 55P
- Diener, H.C., 1995. For the RPR 100,893 Migraine Study Group. Proc. 6th Int. Headache Res. Sem., Abs. 63.
- Geppetti, P., Holzer, P., 1996. Neurogenic Inflammation. CRC Press Inc., Boca Raton.
- Jancsó, 1967, Direct evidence of neurogenic inflammation and its prevention by denervation and by treatment with capsaicin, Br. J. Pharmacol., 31, 138
- Ziche, 1996, Angiogenesis, Exp. Nephrol., 4, 1
Cited by
Sorted by citations
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765
Self-citationInnervation of ectopic endometrium in a rat model of endometriosis
Berkley, K. J., Dmitrieva, N., Curtis, K. S., & Papka, R. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403663101 · Cited by 227
Yan, D., Liu, X., & Guo, S.-W. (2019) · Scientific Reports · doi:10.1038/s41598-019-39170-w · Cited by 82
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
Monaco-Shawver, L., Schwartz, L., Tuluc, F., Guo, C.-J., Lai, J. P., Gunnam, S. M., Kilpatrick, L. E., Banerjee, P. P., Douglas, S. D., & Orange, J. S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410200 · Cited by 39
Metadata
- Authors
- Brain, S. D.
- Affiliations
- King's College London (GB)
- Corresponding author
- Brain, Susan D
- ORCID
- Brain, Susan D
- Venue
- Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 37
- Issue
- 2-3
- Pages
- 133-152
- ISSN
- 0162-3109 (ISSN-L)
- OpenAlex
- W2086969402
- Cited by
- 246
- References
- 205
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 10 · 2023: 2 · 2022: 5 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 6 · 2017: 3 · 2016: 8 · 2015: 11 · 2014: 11 · 2013: 13 · 2012: 9
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- sensory neuropeptides, substance P, calcitonin gene-related peptide, tachykinin NK1 receptor, tachykinin NK2 receptor, CGRP1 receptor, inflammation, wound healing, sensory nerves, microvascular tone, microvascular permeability, neuropeptide antagonists, perivascular nerves
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Inflammation, Molecular Sequence Data, Neurons, Afferent, Neuropeptides, Wound Healing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
